Hepion Pharmaceuticals, Inc.

HEPA · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$13-$49-$42-$33
Dep. & Amort.$0$0$0$0
Deferred Tax$0-$0$0$0
Stock-Based Comp.$1$1$3$5
Change in WC-$3$3$3-$6
Other Non-Cash-$3$4$1$2
Operating Cash Flow-$18-$41-$35-$31
Investing Activities
PP&E Inv.$0-$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$1$0$0$0
Investing Cash Flow-$1-$0-$0-$0
Financing Activities
Debt Repay.$0$0$0-$0
Stock Issued$3$0$0$82
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$2$4-$5$0
Financing Cash Flow$4$4-$5$82
Forex Effect$0$0-$0$0
Net Chg. in Cash-$14-$36-$40$51
Supplemental Information
Beg. Cash$15$51$91$41
End Cash$0$15$51$91
Free Cash Flow-$18-$41-$35-$31